Journal of Neurology

, Volume 259, Issue 2, pp 201–211

Progress in Alzheimer’s disease


DOI: 10.1007/s00415-011-6145-3

Cite this article as:
Galimberti, D. & Scarpini, E. J Neurol (2012) 259: 201. doi:10.1007/s00415-011-6145-3


After more than one century from Alois Alzheimer and Gaetano Perusini’s first report, progress has been made in understanding the pathogenic steps of Alzheimer’s disease (AD), as well as in its early diagnosis. This review discusses recent findings leading to the formulation of novel criteria for diagnosis of the disease even in a preclinical phase, by using biological markers. In addition, treatment options will be discussed, with emphasis on new disease-modifying compounds and future trial design suitable to test these drugs in an early phase of the disease.


Alzheimer’s disease Amyloid Tau Inflammation Genetics Biomarkers Diagnosis Disease-modifying drugs 

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Department of Neurological Sciences, “Dino Ferrari” Center, Fondazione Cà Granda, IRCCS Ospedale Maggiore PoliclinicoUniversity of MilanMilanItaly

Personalised recommendations